Trials / Terminated
TerminatedNCT01103908
Cardiac Output Measurement at the Conclusion of Cardiopulmonary Bypass
Ultrasound Dilution Cardiac Output at the Conclusion of Cardiopulmonary Bypass in Pediatric Patients
- Status
- Terminated
- Phase
- —
- Study type
- Observational
- Enrollment
- 3 (actual)
- Sponsor
- Transonic Systems Inc. · Industry
- Sex
- All
- Age
- 21 Years
- Healthy volunteers
- Not accepted
Summary
Cardiac output, the amount of blood pumped by the heart in one minute, will be measured in pediatric patients undergoing surgery involving cardiopulmonary bypass (CPB). Cardiac output will be measured after cardiopulmonary bypass using a device that employs ultrasound dilution technology. At times, cardiac output will be measured during a procedure called modified ultrafiltration (MUF). The ultrasound dilution cardiac output measurements will be validated or compared with cardiac output measurements made using other FDA approved techniques and devices.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | HCE101 Cardiopulmonary Support Monitor | Measurement of cardiac output using ultrasound dilution technology. The ultrasound dilution technology is in the HCE101 Cardiopulmonary Support Monitor. |
Timeline
- Start date
- 2010-04-01
- Primary completion
- 2010-12-01
- Completion
- 2011-08-01
- First posted
- 2010-04-15
- Last updated
- 2016-05-27
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT01103908. Inclusion in this directory is not an endorsement.